MINZOYA

Serial Number 97526725
Registration 7803938
700

Registration Progress

Application Filed
Jul 29, 2022
Under Examination
Aug 22, 2023
Approved for Publication
Jun 27, 2023
Published for Opposition
Jun 27, 2023
Registered
May 20, 2025

Trademark Image

MINZOYA

Basic Information

Serial Number
97526725
Registration Number
7803938
Filing Date
July 29, 2022
Registration Date
May 20, 2025
Published for Opposition
June 27, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
May 20, 2025
Registration
Registered
Classes
005

Rights Holder

Lupin Limited

99
Address
Bandra Kurla Complex -- Bandra (W) B/4
Laxmi Towers
Mumbai 400051
IN

Ownership History

Lupin Limited

Original Applicant
99
Mumbai IN

Lupin Limited

Owner at Publication
99
Mumbai IN

Lupin Limited

Original Registrant
99
Mumbai IN

Legal Representation

Attorney
Robert L. Powley

USPTO Deadlines

Next Deadline
2115 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-05-20)
Due Date
May 20, 2031
Grace Period Ends
November 20, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

28 events
Date Code Type Description Documents
May 20, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
May 20, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 25, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Apr 25, 2025 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Apr 25, 2025 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Apr 25, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 11, 2025 IUAF S USE AMENDMENT FILED Loading...
Feb 11, 2025 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Aug 20, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Aug 20, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Aug 20, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 20, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 23, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 22, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 22, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 22, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 22, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 27, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 27, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 7, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 19, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 18, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
May 18, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
May 18, 2023 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
May 18, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
May 16, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 20, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 2, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceuticals, namely, oral contraceptives; oral hormonal contraceptives; contraceptive preparations; hormone replacement therapy preparations; hormonal agents for treating disorders and conditions related to women's health, namely, symptoms and conditions associated with menopause, pre-menstruation syndrome and other symptoms and conditions associated with menstruation; transdermal patches featuring contraceptive preparations
First Use Anywhere: Feb 10, 2025
First Use in Commerce: Feb 10, 2025

Classification

International Classes
005